Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lot Quality Assurance Sampling | 8 | 2015 | 17 | 2.900 |
Why?
|
Disease Outbreaks | 13 | 2021 | 1729 | 1.540 |
Why?
|
Schistosoma mansoni | 3 | 2012 | 153 | 0.880 |
Why?
|
Schistosomiasis mansoni | 2 | 2012 | 90 | 0.800 |
Why?
|
Cluster Analysis | 8 | 2015 | 2673 | 0.700 |
Why?
|
Space-Time Clustering | 2 | 2009 | 46 | 0.660 |
Why?
|
Sentinel Surveillance | 3 | 2011 | 281 | 0.640 |
Why?
|
Quality Assurance, Health Care | 5 | 2015 | 2166 | 0.630 |
Why?
|
Program Evaluation | 5 | 2018 | 2455 | 0.630 |
Why?
|
Poliomyelitis | 2 | 2018 | 94 | 0.590 |
Why?
|
Population Surveillance | 6 | 2014 | 2587 | 0.580 |
Why?
|
Influenza, Human | 4 | 2013 | 1503 | 0.540 |
Why?
|
Parasite Egg Count | 2 | 2012 | 28 | 0.540 |
Why?
|
Basic Reproduction Number | 2 | 2021 | 34 | 0.540 |
Why?
|
Sampling Studies | 2 | 2015 | 617 | 0.530 |
Why?
|
Drug Resistance, Viral | 2 | 2013 | 837 | 0.500 |
Why?
|
Entropy | 1 | 2015 | 207 | 0.490 |
Why?
|
Bayes Theorem | 2 | 2013 | 2276 | 0.490 |
Why?
|
Data Interpretation, Statistical | 4 | 2013 | 2689 | 0.470 |
Why?
|
HIV-1 | 4 | 2015 | 6872 | 0.420 |
Why?
|
Mass Vaccination | 1 | 2014 | 105 | 0.420 |
Why?
|
Data Collection | 3 | 2014 | 3297 | 0.410 |
Why?
|
Tuberculosis, Pulmonary | 4 | 2016 | 806 | 0.400 |
Why?
|
Crime Victims | 1 | 2015 | 319 | 0.390 |
Why?
|
Health Surveys | 3 | 2015 | 3961 | 0.360 |
Why?
|
Computer Simulation | 9 | 2018 | 6151 | 0.350 |
Why?
|
Public Sector | 2 | 2012 | 261 | 0.340 |
Why?
|
Influenza A Virus, H1N1 Subtype | 2 | 2012 | 444 | 0.340 |
Why?
|
HIV Infections | 6 | 2015 | 16939 | 0.330 |
Why?
|
Biostatistics | 1 | 2011 | 163 | 0.330 |
Why?
|
Tuberculosis, Multidrug-Resistant | 5 | 2016 | 918 | 0.320 |
Why?
|
Immunization | 1 | 2013 | 1220 | 0.310 |
Why?
|
Epidemiologic Methods | 1 | 2013 | 1338 | 0.310 |
Why?
|
Topography, Medical | 1 | 2007 | 37 | 0.300 |
Why?
|
Firearms | 1 | 2015 | 615 | 0.300 |
Why?
|
Disease Transmission, Infectious | 1 | 2013 | 556 | 0.300 |
Why?
|
Leukemia | 2 | 2014 | 1500 | 0.290 |
Why?
|
Research Design | 2 | 2021 | 6066 | 0.290 |
Why?
|
Health Care Surveys | 1 | 2014 | 2418 | 0.280 |
Why?
|
Sample Size | 3 | 2015 | 832 | 0.260 |
Why?
|
Health Status Indicators | 1 | 2011 | 960 | 0.260 |
Why?
|
HIV | 1 | 2012 | 1585 | 0.250 |
Why?
|
Epidemiologic Measurements | 1 | 2004 | 22 | 0.250 |
Why?
|
Prevalence | 10 | 2022 | 15308 | 0.240 |
Why?
|
Models, Statistical | 6 | 2015 | 5038 | 0.240 |
Why?
|
Drug Resistance, Bacterial | 1 | 2010 | 1021 | 0.210 |
Why?
|
Decision Support Techniques | 1 | 2012 | 1958 | 0.210 |
Why?
|
Health Status | 1 | 2015 | 4022 | 0.200 |
Why?
|
Delivery of Health Care | 2 | 2018 | 5259 | 0.190 |
Why?
|
DNA, Viral | 1 | 2007 | 2173 | 0.180 |
Why?
|
Infant, Very Low Birth Weight | 2 | 2002 | 394 | 0.180 |
Why?
|
Anti-HIV Agents | 2 | 2013 | 4413 | 0.170 |
Why?
|
Phylogeny | 1 | 2007 | 2735 | 0.170 |
Why?
|
Humans | 52 | 2022 | 746897 | 0.170 |
Why?
|
Antitubercular Agents | 3 | 2016 | 1346 | 0.170 |
Why?
|
Infant, Premature, Diseases | 2 | 2002 | 699 | 0.160 |
Why?
|
Pandemics | 3 | 2020 | 8445 | 0.160 |
Why?
|
Statistics as Topic | 1 | 2005 | 2342 | 0.160 |
Why?
|
Evolution, Molecular | 1 | 2007 | 1880 | 0.160 |
Why?
|
Infant, Extremely Low Birth Weight | 2 | 2009 | 82 | 0.160 |
Why?
|
Algorithms | 6 | 2015 | 13816 | 0.150 |
Why?
|
New York | 2 | 2014 | 868 | 0.150 |
Why?
|
Likelihood Functions | 2 | 2013 | 985 | 0.150 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2002 | 490 | 0.140 |
Why?
|
Models, Genetic | 1 | 2007 | 3425 | 0.140 |
Why?
|
Mass Screening | 1 | 2012 | 5331 | 0.140 |
Why?
|
Chronic Disease | 2 | 2011 | 9128 | 0.140 |
Why?
|
Echoencephalography | 3 | 2008 | 133 | 0.140 |
Why?
|
Environmental Exposure | 1 | 2011 | 4320 | 0.140 |
Why?
|
Infection Control | 2 | 2015 | 972 | 0.140 |
Why?
|
Morbidity | 1 | 2021 | 1744 | 0.130 |
Why?
|
Ventilation | 1 | 2015 | 124 | 0.120 |
Why?
|
Sensitivity and Specificity | 4 | 2015 | 14546 | 0.120 |
Why?
|
Geographic Information Systems | 2 | 2014 | 277 | 0.120 |
Why?
|
Rifampin | 1 | 2016 | 326 | 0.120 |
Why?
|
Prenatal Care | 1 | 2022 | 1085 | 0.120 |
Why?
|
Florida | 1 | 2015 | 412 | 0.120 |
Why?
|
Cerebral Palsy | 2 | 2009 | 466 | 0.110 |
Why?
|
Local Government | 1 | 2014 | 80 | 0.110 |
Why?
|
Disinfection | 1 | 2015 | 210 | 0.110 |
Why?
|
Residence Characteristics | 2 | 2015 | 2003 | 0.110 |
Why?
|
Child Health Services | 1 | 2018 | 655 | 0.110 |
Why?
|
Africa, Eastern | 1 | 2012 | 72 | 0.110 |
Why?
|
Measles Vaccine | 1 | 2013 | 77 | 0.110 |
Why?
|
Anthelmintics | 1 | 2012 | 74 | 0.100 |
Why?
|
United Nations | 1 | 2013 | 156 | 0.100 |
Why?
|
Regression Analysis | 2 | 2015 | 6338 | 0.100 |
Why?
|
Cerebral Hemorrhage | 2 | 2009 | 2617 | 0.100 |
Why?
|
South Africa | 2 | 2013 | 1748 | 0.090 |
Why?
|
Health Services Research | 1 | 2018 | 1815 | 0.090 |
Why?
|
Models, Theoretical | 2 | 2015 | 3555 | 0.090 |
Why?
|
Total Quality Management | 1 | 2012 | 268 | 0.090 |
Why?
|
Nigeria | 1 | 2014 | 753 | 0.090 |
Why?
|
Uganda | 1 | 2015 | 1297 | 0.090 |
Why?
|
Micronutrients | 1 | 2013 | 377 | 0.090 |
Why?
|
Ultraviolet Rays | 1 | 2015 | 1059 | 0.090 |
Why?
|
Mosquito Nets | 1 | 2010 | 5 | 0.090 |
Why?
|
Chemoprevention | 1 | 2012 | 325 | 0.090 |
Why?
|
Culex | 1 | 2009 | 17 | 0.090 |
Why?
|
Cost Control | 1 | 2012 | 624 | 0.090 |
Why?
|
Costs and Cost Analysis | 1 | 2015 | 1660 | 0.090 |
Why?
|
Developmental Disabilities | 2 | 2009 | 1495 | 0.090 |
Why?
|
Masks | 1 | 2012 | 200 | 0.080 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2013 | 359 | 0.080 |
Why?
|
West Nile Fever | 1 | 2009 | 75 | 0.080 |
Why?
|
Insect Vectors | 1 | 2009 | 133 | 0.080 |
Why?
|
Infant, Newborn | 8 | 2022 | 25765 | 0.080 |
Why?
|
Health Personnel | 1 | 2022 | 3230 | 0.080 |
Why?
|
Uncertainty | 1 | 2013 | 741 | 0.080 |
Why?
|
Incidence | 3 | 2015 | 20822 | 0.070 |
Why?
|
Infant | 5 | 2018 | 35465 | 0.070 |
Why?
|
Urban Population | 1 | 2015 | 1990 | 0.070 |
Why?
|
Child | 6 | 2018 | 78517 | 0.070 |
Why?
|
Child, Preschool | 6 | 2018 | 41406 | 0.070 |
Why?
|
Cleft Lip | 1 | 2012 | 490 | 0.070 |
Why?
|
Folic Acid | 1 | 2013 | 1284 | 0.070 |
Why?
|
Influenza A Virus, H5N1 Subtype | 1 | 2008 | 113 | 0.070 |
Why?
|
Gastrointestinal Tract | 1 | 2013 | 825 | 0.070 |
Why?
|
Cleft Palate | 1 | 2012 | 570 | 0.070 |
Why?
|
Software | 1 | 2021 | 4401 | 0.070 |
Why?
|
Demography | 3 | 2009 | 1630 | 0.070 |
Why?
|
Vaccination | 1 | 2018 | 3283 | 0.070 |
Why?
|
Iron | 1 | 2013 | 1737 | 0.060 |
Why?
|
Rural Population | 1 | 2015 | 2207 | 0.060 |
Why?
|
Birth Weight | 1 | 2013 | 2060 | 0.060 |
Why?
|
Predictive Value of Tests | 2 | 2013 | 15010 | 0.060 |
Why?
|
Male | 12 | 2016 | 351556 | 0.060 |
Why?
|
Sputum | 2 | 2016 | 488 | 0.060 |
Why?
|
India | 1 | 2010 | 2247 | 0.060 |
Why?
|
Computer Systems | 1 | 2005 | 471 | 0.060 |
Why?
|
Female | 15 | 2022 | 382617 | 0.060 |
Why?
|
Psychomotor Performance | 2 | 2009 | 1867 | 0.060 |
Why?
|
Confidentiality | 1 | 2007 | 608 | 0.050 |
Why?
|
Head | 1 | 2009 | 899 | 0.050 |
Why?
|
Weight Gain | 1 | 2013 | 2314 | 0.050 |
Why?
|
Selection Bias | 1 | 2004 | 358 | 0.050 |
Why?
|
Tuberculosis | 1 | 2015 | 1957 | 0.050 |
Why?
|
Anti-Retroviral Agents | 1 | 2012 | 1755 | 0.050 |
Why?
|
Bioterrorism | 1 | 2003 | 144 | 0.050 |
Why?
|
Triplets | 1 | 2002 | 43 | 0.050 |
Why?
|
ROC Curve | 1 | 2010 | 3500 | 0.050 |
Why?
|
Guinea Pigs | 2 | 2015 | 1314 | 0.050 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2009 | 793 | 0.050 |
Why?
|
Patient Admission | 1 | 2009 | 1359 | 0.050 |
Why?
|
Decision Making | 1 | 2015 | 3856 | 0.050 |
Why?
|
Alleles | 1 | 2012 | 6841 | 0.050 |
Why?
|
Brain Damage, Chronic | 1 | 2002 | 267 | 0.050 |
Why?
|
Chorioamnionitis | 1 | 2002 | 156 | 0.050 |
Why?
|
Leukomalacia, Periventricular | 1 | 2002 | 185 | 0.050 |
Why?
|
Twins | 1 | 2002 | 335 | 0.040 |
Why?
|
Adult | 8 | 2016 | 215291 | 0.040 |
Why?
|
Malaria | 1 | 2010 | 1203 | 0.040 |
Why?
|
Computational Biology | 2 | 2013 | 3489 | 0.040 |
Why?
|
Public Health | 1 | 2013 | 2622 | 0.040 |
Why?
|
Neutrophil Infiltration | 1 | 2002 | 389 | 0.040 |
Why?
|
History, 20th Century | 1 | 2008 | 2739 | 0.040 |
Why?
|
Gestational Age | 1 | 2008 | 3527 | 0.040 |
Why?
|
Monte Carlo Method | 1 | 2005 | 1268 | 0.040 |
Why?
|
Animals | 6 | 2015 | 166593 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 10096 | 0.040 |
Why?
|
Brain Diseases | 1 | 2008 | 1539 | 0.040 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 25197 | 0.040 |
Why?
|
Adolescent | 4 | 2015 | 86323 | 0.040 |
Why?
|
Madagascar | 1 | 2018 | 111 | 0.040 |
Why?
|
DNA Mutational Analysis | 1 | 2007 | 4125 | 0.040 |
Why?
|
Microbial Sensitivity Tests | 2 | 2016 | 1861 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2021 | 63767 | 0.040 |
Why?
|
Respiratory Tract Infections | 1 | 2005 | 984 | 0.040 |
Why?
|
Child Development | 1 | 2008 | 2251 | 0.030 |
Why?
|
Massachusetts | 1 | 2009 | 8610 | 0.030 |
Why?
|
Fetal Diseases | 1 | 2002 | 910 | 0.030 |
Why?
|
Immunization Programs | 1 | 2018 | 261 | 0.030 |
Why?
|
Hypotension | 1 | 2002 | 867 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 2007 | 4711 | 0.030 |
Why?
|
Placenta | 2 | 2002 | 1688 | 0.030 |
Why?
|
Genetic Variation | 2 | 2009 | 6455 | 0.030 |
Why?
|
Neurologic Examination | 2 | 2009 | 917 | 0.030 |
Why?
|
Tuberculin Test | 1 | 2015 | 205 | 0.030 |
Why?
|
Uzbekistan | 1 | 2013 | 1 | 0.030 |
Why?
|
Bread | 1 | 2013 | 23 | 0.030 |
Why?
|
Flour | 1 | 2013 | 20 | 0.030 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2016 | 627 | 0.030 |
Why?
|
Mycobacterium tuberculosis | 2 | 2016 | 1858 | 0.030 |
Why?
|
Pregnancy | 4 | 2022 | 29314 | 0.030 |
Why?
|
Folic Acid Deficiency | 1 | 2013 | 115 | 0.030 |
Why?
|
Organization and Administration | 1 | 2012 | 54 | 0.030 |
Why?
|
Stomach Neoplasms | 1 | 2002 | 1361 | 0.030 |
Why?
|
Food, Fortified | 1 | 2013 | 186 | 0.030 |
Why?
|
Surgical Procedures, Operative | 1 | 2003 | 1837 | 0.020 |
Why?
|
Lung Diseases | 1 | 2002 | 1903 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2016 | 1678 | 0.020 |
Why?
|
Malawi | 1 | 2012 | 296 | 0.020 |
Why?
|
Models, Biological | 1 | 2007 | 9466 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2002 | 2852 | 0.020 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2012 | 367 | 0.020 |
Why?
|
Critical Care | 1 | 2003 | 2660 | 0.020 |
Why?
|
Treatment Failure | 1 | 2016 | 2616 | 0.020 |
Why?
|
Retreatment | 1 | 2012 | 600 | 0.020 |
Why?
|
Mozambique | 1 | 2010 | 54 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2003 | 3674 | 0.020 |
Why?
|
Neutrophils | 1 | 2002 | 3709 | 0.020 |
Why?
|
Middle Aged | 5 | 2016 | 214711 | 0.020 |
Why?
|
Insecticide-Treated Bednets | 1 | 2010 | 62 | 0.020 |
Why?
|
Private Sector | 1 | 2012 | 392 | 0.020 |
Why?
|
Risk Factors | 2 | 2014 | 72453 | 0.020 |
Why?
|
Young Adult | 1 | 2015 | 57221 | 0.020 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2012 | 248 | 0.020 |
Why?
|
Peru | 1 | 2012 | 847 | 0.020 |
Why?
|
CD-ROM | 1 | 2008 | 24 | 0.020 |
Why?
|
Certification | 1 | 2012 | 417 | 0.020 |
Why?
|
Administration, Oral | 1 | 2016 | 3978 | 0.020 |
Why?
|
Mutation | 1 | 2013 | 29643 | 0.020 |
Why?
|
Hemiplegia | 1 | 2008 | 135 | 0.020 |
Why?
|
Hemoglobins | 1 | 2013 | 1511 | 0.020 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2012 | 569 | 0.020 |
Why?
|
Microsatellite Repeats | 1 | 2009 | 784 | 0.020 |
Why?
|
Logistic Models | 1 | 2002 | 13171 | 0.020 |
Why?
|
Risk Assessment | 2 | 2014 | 23470 | 0.020 |
Why?
|
United States | 3 | 2009 | 70460 | 0.020 |
Why?
|
Feces | 1 | 2013 | 1432 | 0.020 |
Why?
|
Quadriplegia | 1 | 2008 | 223 | 0.020 |
Why?
|
Cohort Studies | 3 | 2016 | 40540 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6463 | 0.020 |
Why?
|
Benchmarking | 1 | 2012 | 1030 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2003 | 5242 | 0.020 |
Why?
|
Gene Frequency | 1 | 2012 | 3534 | 0.020 |
Why?
|
Risk | 1 | 2016 | 9522 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 10745 | 0.010 |
Why?
|
Canada | 1 | 2009 | 2090 | 0.010 |
Why?
|
Microcephaly | 1 | 2008 | 429 | 0.010 |
Why?
|
Geography | 1 | 2005 | 653 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2009 | 2920 | 0.010 |
Why?
|
Public Health Administration | 1 | 2005 | 246 | 0.010 |
Why?
|
Cost of Illness | 1 | 2012 | 1877 | 0.010 |
Why?
|
Infant, Premature | 2 | 2002 | 2042 | 0.010 |
Why?
|
Ureaplasma | 1 | 2002 | 59 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 2012 | 19827 | 0.010 |
Why?
|
Bacteria | 1 | 2013 | 2139 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12281 | 0.010 |
Why?
|
Medical History Taking | 1 | 2005 | 772 | 0.010 |
Why?
|
Brain | 2 | 2012 | 26606 | 0.010 |
Why?
|
Patient Care Team | 1 | 2012 | 2480 | 0.010 |
Why?
|
Respiration, Artificial | 2 | 2002 | 2573 | 0.010 |
Why?
|
Italy | 1 | 2002 | 825 | 0.010 |
Why?
|
Calibration | 1 | 2003 | 803 | 0.010 |
Why?
|
Appointments and Schedules | 1 | 2003 | 428 | 0.010 |
Why?
|
Motor Activity | 1 | 2009 | 2670 | 0.010 |
Why?
|
Multivariate Analysis | 2 | 2002 | 12021 | 0.010 |
Why?
|
Genotype | 1 | 2012 | 12790 | 0.010 |
Why?
|
Gastrectomy | 1 | 2002 | 671 | 0.010 |
Why?
|
Vasodilator Agents | 1 | 2002 | 957 | 0.010 |
Why?
|
Registries | 1 | 2012 | 8176 | 0.010 |
Why?
|
DNA | 1 | 2009 | 7214 | 0.010 |
Why?
|
Ultrasonography | 1 | 2009 | 5903 | 0.010 |
Why?
|
Health Services Needs and Demand | 1 | 2003 | 1391 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2002 | 2919 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2005 | 2731 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2008 | 38812 | 0.010 |
Why?
|
Hospitals, Pediatric | 1 | 2003 | 1816 | 0.010 |
Why?
|
Inflammation | 1 | 2013 | 10642 | 0.010 |
Why?
|
Comorbidity | 1 | 2008 | 10378 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2012 | 12216 | 0.010 |
Why?
|
Prospective Studies | 2 | 2012 | 53276 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2008 | 12842 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2012 | 78361 | 0.010 |
Why?
|
Emergency Medical Services | 1 | 2003 | 1887 | 0.010 |
Why?
|
Cognition | 1 | 2008 | 6786 | 0.010 |
Why?
|
Time Factors | 1 | 2012 | 39639 | 0.010 |
Why?
|
Boston | 1 | 2003 | 9213 | 0.010 |
Why?
|
Survival Analysis | 1 | 2002 | 10139 | 0.010 |
Why?
|
Sex Factors | 1 | 2002 | 10287 | 0.000 |
Why?
|
Survival Rate | 1 | 2002 | 12651 | 0.000 |
Why?
|
Pregnancy Complications | 1 | 2002 | 2890 | 0.000 |
Why?
|
Sepsis | 1 | 2002 | 2585 | 0.000 |
Why?
|
Emergency Service, Hospital | 1 | 2005 | 7706 | 0.000 |
Why?
|
Age Factors | 1 | 2002 | 18160 | 0.000 |
Why?
|
Case-Control Studies | 1 | 2002 | 21702 | 0.000 |
Why?
|
Prognosis | 1 | 2002 | 29088 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2009 | 35829 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2002 | 57627 | 0.000 |
Why?
|
Aged | 1 | 2002 | 164472 | 0.000 |
Why?
|